ArticleBMC medical informatics and decision making2018
Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease: a feature selection ensemble combining stability and predictability.
Article in BMC medical informatics and decision making, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Low Sensitivity of Neuropsychological Scales Hinder Detection of Potential Benefit of Treatments in Alzheimer's Disease: A Position Paper.European journal of neurology · 2026Review
- Identifying dementia neuropathology using low-burden clinical data.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- A Systematic Review on Subjective Cognitive Complaints: Main Neurocognitive Domains, Myriad Assessment Tools, and New Approaches for Early Detection.Geriatrics (Basel, Switzerland) · 2025Review
- Preclinical Cognitive Markers of Alzheimer Disease and Early Diagnosis Using Virtual Reality and Artificial Intelligence: Literature Review.JMIR medical informatics · 2025Review
- Predicting cognitive change using functional, structural, and neuropsychological predictors.Brain communications · 2025Article
- Premenstrual dysphoric disorder as a potential predisposing factor for Alzheimer's disease: a review.Frontiers in endocrinology · 2025Review
- Predicting amyloid status in mild cognitive impairment: the role of semantic intrusions combined with plasma biomarkers.Frontiers in aging neuroscience · 2025Article
- Prediction of Alzheimer's disease progression within 6 years using speech: A novel approach leveraging language models.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Article
- Verbal fluency patterns associated with the amnestic conversion from mild cognitive impairment to dementia.Scientific reports · 2024Article
- Synthetic data analysis for early detection of Alzheimer progression through machine learning algorithms.PeerJ. Computer science · 2024Article
- Differentiating Alzheimer's disease from mild cognitive impairment: a quick screening tool based on machine learning.BMJ open · 2023Article
- Dementia prediction in the general population using clinically accessible variables: a proof-of-concept study using machine learning. The AGES-Reykjavik study.BMC medical informatics and decision making · 2023Article
- Prediction of Tinnitus Treatment Outcomes Based on EEG Sensors and TFI Score Using Deep Learning.Sensors (Basel, Switzerland) · 2023Article
- Constructing a prognostic risk model for Alzheimer's disease based on ferroptosis.Frontiers in aging neuroscience · 2023Article
- Examining Cognitive Factors for Alzheimer's Disease Progression Using Computational Intelligence.Healthcare (Basel, Switzerland) · 2022Article
- A robust framework to investigate the reliability and stability of explainable artificial intelligence markers of Mild Cognitive Impairment and Alzheimer's Disease.Brain informatics · 2022Article
- Speech- and Language-Based Classification of Alzheimer's Disease: A Systematic Review.Bioengineering (Basel, Switzerland) · 2022Review
- Early MCI-to-AD Conversion Prediction Using Future Value Forecasting of Multimodal Features.Computational intelligence and neuroscience · 2021Article
- Quantification of cognitive impairment to characterize heterogeneity of patients at risk of developing Alzheimer's disease dementia.Alzheimer's & dementia (Amsterdam, Netherlands) · 2021Article
- Screening for Early-Stage Alzheimer's Disease Using Optimized Feature Sets and Machine Learning.Journal of Alzheimer's disease : JAD · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundPredicting progression from Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) is an utmost open issue in AD-related research. Neuropsychological assessment has proven to be useful in identifying MCI patients who are likely to convert to dementia. However, the large battery of neuropsychological tests (NPTs) performed in clinical practice and the limited number of training examples are challenge to machine learning when learning prognostic models. In this context, it is paramount to pursue approaches that effectively seek for reduced sets of relevant features. Subsets of NPTs from which prognostic models can be learnt should not only be good predictors, but also stable, promoting generalizable and explainable models.
methodsWe propose a feature selection (FS) ensemble combining stability and predictability to choose the most relevant NPTs for prognostic prediction in AD. First, we combine the outcome of multiple (filter and embedded) FS methods. Then, we use a wrapper-based approach optimizing both stability and predictability to compute the number of selected features. We use two large prospective studies (ADNI and the Portuguese Cognitive Complaints Cohort, CCC) to evaluate the approach and assess the predictive value of a large number of NPTs.
resultsThe best subsets of features include approximately 30 and 20 (from the original 79 and 40) features, for ADNI and CCC data, respectively, yielding stability above 0.89 and 0.95, and AUC above 0.87 and 0.82. Most NPTs learnt using the proposed feature selection ensemble have been identified in the literature as strong predictors of conversion from MCI to AD.
conclusionsThe FS ensemble approach was able to 1) identify subsets of stable and relevant predictors from a consensus of multiple FS methods using baseline NPTs and 2) learn reliable prognostic models of conversion from MCI to AD using these subsets of features. The machine learning models learnt from these features outperformed the models trained without FS and achieved competitive results when compared to commonly used FS algorithms. Furthermore, the selected features are derived from a consensus of methods thus being more robust, while releasing users from choosing the most appropriate FS method to be used in their classification task.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.